国药一致：2025年上半年实现营业总收入3679659.84万元

Core Viewpoint - The company reported a decline in both total revenue and net profit for the first half of 2025 compared to the previous year [2] Financial Performance - The total operating revenue for the first half of 2025 was 36,796.60 million yuan, representing a year-on-year decrease of 2.62% [2] - The net profit attributable to shareholders of the listed company was 665.91 million yuan, showing a year-on-year decline of 10.43% [2]